Comparison

MS417 European Partner

Item no. TMO-T16154-50mg
Manufacturer TargetMol
CASRN 916489-36-6
Amount 50mg
Category
Type Inhibitors
Specific against other
Purity 99.88%
Citations Zhang G, et al. Down-regulation of NF-kappaB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem. 2012 Aug 17;287(34):28840-51.
Smiles COC(=O)C[C@@H]1N=C(C2=C(SC(C)=C2C)N2C(C)=NN=C12)C1=CC=C(Cl)C=C1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 916489-36-6, Epigenetic Reader Domain, GTPL7512
Available
Short Description
MS417 is an inhibitor of BET-specific BRD4(BRD4-BD1 and BRD4-BD2 with IC50s of 30, 46 nM and Kds of 36.1, 25.4 nM, respectively), with weak selectivity at CBP BRD with IC50 of 32.7 μM.
Shipping
cool pack
Storage
-20°
Target names or alias
GTPL7512
Molecular Weight
414, 91
Pathway
Chromatin/Epigenetic|||Proteases/Proteasome|||Microbiology/Virology
Target
HIV Protease|||Epigenetic Reader Domain

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close